MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/art.70146

Медицинская библиотека · Arthritis & rheumatology (Hoboken, N.J.) · 2026

A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.

Chen Longfang, Dai Qihua, Xiao Yu, Dai Jialin, Wang Mengyan, Ma Yuning, Shen Yujie, Xu Zhimo, Meng Jianfen, Chen Xia, Yi Da, Sun Yue, Shi Hui, Liu Honglei, Cheng Xiaobing, Su Yutong, Ye Junna, Chi Huihui, Zhou Zhuochao, Liu Tingting, Teng Jialin, Yang Chengde, Jia Jinchao, Hu Qiongyi

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

Still disease represents a prototypical polygenic systemic autoinflammatory disease, characterized by recurrent systemic inflammation and dysregulation of innate immunity. Despite extensive clinical characterization, familial clustering Still disease remains unreported. This study investigates a novel variant underlying a distinct Still disease-like autoinflammatory syndrome.

METHODS

Whole-exome sequencing was performed in a three-generation family with three affected individuals. Functional analyses were conducted to assess the impact of the receptor-interacting protein kinase 3 (RIPK3) p.Q134K variant on kinase activity, necroptosis, and inflammatory signaling. Transcriptomic profiling of peripheral blood mononuclear cells (PBMCs) and in vitro cytokine assays were used to characterize inflammatory responses.

RESULTS

A heterozygous RIPK3 p.Q134K variant was identified in all affected individuals. Functional analyses demonstrated that this variant exhibits gain-of-function activity, characterized by enhanced RIPK3 kinase activity and increased RIPK3 self-association, which in turn promote mixed-lineage kinase domain-like protein phosphorylation and necroptosis. RNA sequencing of PBMCs from one patient revealed marked up-regulation of NF-κB and MAPK signaling pathways and elevated expression of interleukin-6, and tumor necrosis factor-α, which was effectively suppressed by pharmacologic inhibition of RIPK3.

CONCLUSION

This study describes a familial Still disease-like autoinflammatory syndrome caused by a gain-of-function RIPK3 variant. Our findings establish aberrant RIPK3 activation as a driver of autoinflammation and expand the spectrum of human RIPK3-associated diseases.

Для цитирования: Chen Longfang, Dai Qihua, Xiao Yu, Dai Jialin, Wang Mengyan, Ma Yuning, Shen Yujie, Xu Zhimo, Meng Jianfen, Chen Xia, Yi Da, Sun Yue, Shi Hui, Liu Honglei, Cheng Xiaobing, Su Yutong, Ye Junna, Chi Huihui, Zhou Zhuochao, Liu Tingting, Teng Jialin, Yang Chengde, Jia Jinchao, Hu Qiongyi. A Rare RIPK3 Variant Enhances Necroptosis and Promotes Inflammation in a Still Disease-Like Autoinflammatory Syndrome.. Arthritis & rheumatology (Hoboken, N.J.). 2026. DOI: 10.1002/art.70146.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.